MGNXMACROGENICS INC

Nasdaq macrogenics.com


$ 8.27 $ 0.01 (0.07 %)    

Thursday, 09-May-2024 16:15:33 EDT
QQQ $ 441.33 $ 0.96 (0.22 %)
DIA $ 394.43 $ 3.52 (0.9 %)
SPY $ 520.56 $ 2.98 (0.58 %)
TLT $ 90.69 $ 0.44 (0.49 %)
GLD $ 216.93 $ 3.37 (1.58 %)
$ 14.67
$ 14.55
$ 0.00 x 0
$ 0.00 x 0
$ 8.27 - $ 14.85
$ 4.29 - $ 21.88
4,882,225
na
913.8M
$ 1.71
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 03-07-2024 12-31-2023 10-K
3 11-06-2023 09-30-2023 10-Q
4 08-09-2023 06-30-2023 10-Q
5 05-09-2023 03-31-2023 10-Q
6 03-15-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 08-08-2022 06-30-2022 10-Q
9 05-03-2022 03-31-2022 10-Q
10 02-24-2022 12-31-2021 10-K
11 11-02-2021 09-30-2021 10-Q
12 07-29-2021 06-30-2021 10-Q
13 04-29-2021 03-31-2021 10-Q
14 02-25-2021 12-31-2020 10-K
15 11-04-2020 09-30-2020 10-Q
16 07-31-2020 06-30-2020 10-Q
17 05-05-2020 03-31-2020 10-Q
18 02-25-2020 12-31-2019 10-K
19 11-06-2019 09-30-2019 10-Q
20 07-31-2019 06-30-2019 10-Q
21 05-01-2019 03-31-2019 10-Q
22 02-26-2019 12-31-2018 10-K
23 11-07-2018 09-30-2018 10-Q
24 08-07-2018 06-30-2018 10-Q
25 05-07-2018 03-31-2018 10-Q
26 02-27-2018 12-31-2017 10-K
27 11-08-2017 09-30-2017 10-Q
28 08-02-2017 06-30-2017 10-Q
29 05-03-2017 03-31-2017 10-Q
30 02-28-2017 12-31-2016 10-K
31 11-02-2016 09-30-2016 10-Q
32 08-03-2016 06-30-2016 10-Q
33 05-04-2016 03-31-2016 10-Q
34 02-29-2016 12-31-2015 10-K
35 11-04-2015 09-30-2015 10-Q
36 08-05-2015 06-30-2015 10-Q
37 05-06-2015 03-31-2015 10-Q
38 03-03-2015 12-31-2014 10-K
39 11-12-2014 09-30-2014 10-Q
40 08-05-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 td-cowen-downgrades-macrogenics-to-hold

TD Cowen analyst Boris Peaker downgrades Macrogenics (NASDAQ:MGNX) from Buy to Hold.

 stifel-downgrades-macrogenics-to-hold-lowers-price-target-to-7

Stifel analyst Stephen Willey downgrades Macrogenics (NASDAQ:MGNX) from Buy to Hold and lowers the price target from $29 to $7.

 macrogenics-q1-2024-gaap-eps-084-misses-061-estimate-sales-9104m-miss-14617m-estimate

Macrogenics (NASDAQ:MGNX) reported quarterly losses of $(0.84) per share which missed the analyst consensus estimate of $(0.61)...

 td-cowen-upgrades-macrogenics-to-buy

TD Cowen analyst Boris Peaker upgrades Macrogenics (NASDAQ:MGNX) from Hold to Buy.

 look-out-for-these-6-stocks-as-analysts-predicts-major-gains-one-up-to-82

Investment analysts have revised their price targets upwards for six major stocks this week, with one company expected to see a...

 macrogenics-analyst-impressed-by-improved-safety-profile-from-prostate-cancer-candidate

Update on MacroGenics Inc's Phase 2 TAMARACK study of vobramitamab duocarmazine (vobra duo) for metastatic castration-resis...

 why-staar-surgical-shares-are-trading-higher-by-around-13-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of STAAR Surgical Company (NASDAQ: STAA) rose sharply during Thursday’s session after the company issued strong prelimi...

 jmp-securities-reiterates-market-outperform-on-macrogenics

JMP Securities analyst Silvan Tuerkcan reiterates Macrogenics (NASDAQ:MGNX) with a Market Outperform.

 simulations-plus-posts-upbeat-joins-levi-strauss-blackberry-and-other-big-stocks-moving-higher-in-thursdays-pre-market-session

U.S. stock futures were higher this morning, with the Dow futures gaining by around 90 points on Thursday.

 citigroup-maintains-buy-on-macrogenics-raises-price-target-to-25

Citigroup analyst Yigal Nochomovitz maintains Macrogenics (NASDAQ:MGNX) with a Buy and raises the price target from $13 to $25.

 jmp-securities-maintains-outperform-on-macrogenics-raises-price-target-to-22

JMP Securities analyst Silvan Tuerkcan maintains Macrogenics (NASDAQ:MGNX) with a Outperform and raises the price target fro...

 hc-wainwright--co-maintains-neutral-on-macrogenics-raises-price-target-to-16

HC Wainwright & Co. analyst Robert Burns maintains Macrogenics (NASDAQ:MGNX) with a Neutral and raises the price target ...

 bmo-capital-maintains-outperform-on-macrogenics-raises-price-target-to-24

BMO Capital analyst Etzer Darout maintains Macrogenics (NASDAQ:MGNX) with a Outperform and raises the price target from $18 ...

 stifel-maintains-buy-on-macrogenics-raises-price-target-to-29

Stifel analyst Stephen Willey maintains Macrogenics (NASDAQ:MGNX) with a Buy and raises the price target from $17 to $29.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION